Facility

Can BD’s $19B Investment Secure U.S. Medical Supplies?
Management & Regulatory Can BD’s $19B Investment Secure U.S. Medical Supplies?

With BD products being used in ninety percent of U.S. hospital visits, the company's move to solidify domestic production is a cornerstone of national health security. For decades, the globalized medical supply chain prioritized cost efficiency over redundancy, leaving healthcare providers

ZETA and BeneMeat Partner to Scale Up Cultivated Meat
Management & Regulatory ZETA and BeneMeat Partner to Scale Up Cultivated Meat

BeneMeat’s partnership with the Italian brand FORZA10 serves as a practical case study for the commercial application of cultivated cells in the animal feed sector. This collaboration marks a significant milestone in the broader trajectory of cellular agriculture, moving beyond speculative research

How Can US Biomanufacturing Scale for Future Growth?
Management & Regulatory How Can US Biomanufacturing Scale for Future Growth?

Sustainability is increasingly viewed as a risk mitigation strategy rather than a simple cost center, directly enabling a site to double its capacity in the future. As the current landscape of late 2026 unfolds, the American biopharmaceutical manufacturing sector has transitioned from a period of

Mercy Medical Center Earns Top Breast Imaging Accreditation
Management & Regulatory Mercy Medical Center Earns Top Breast Imaging Accreditation

The detection of breast cancer in its most nascent stages remains the single most effective variable in determining long-term patient survival and recovery success. Clinical teams at the Tyanna O’Brien Center utilize ultrasound-guided biopsies and breast MRI to ensure a full spectrum of diagnostic

Can South Korea’s Offensive Strategy Secure Healthcare Data?
Tech & Innovation Can South Korea’s Offensive Strategy Secure Healthcare Data?

Representative Heo Jong-sik presented evidence of eighty confirmed cases where patient procedure videos were leaked, affecting approximately one hundred individual victims across the country. This startling revelation has forced a long-overdue reckoning within the South Korean healthcare system,

How Is Bayer Reshaping Ohio into a Life Sciences Hub?
Management & Regulatory How Is Bayer Reshaping Ohio into a Life Sciences Hub?

By adopting a flexible modular design, Bayer is engineering a manufacturing environment capable of adapting to the rapid evolution of therapeutic drug requirements. This strategic $2.2 billion commitment to establish a state-of-the-art pharmaceutical campus in New Albany, Ohio, marks a significant

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later